Vignesh Packiam, MD

1.7K posts

Vignesh Packiam, MD banner
Vignesh Packiam, MD

Vignesh Packiam, MD

@VigneshPackiam

Associate Prof @RutgersCancer @rwjurology | Previously at @UIowa_Urology | Alum @MayoClinic @Uro_Onc, @UChicagoUro, @PittMedAlum, @UWBadgers| Views my own

New Jersey Katılım Kasım 2013
1.4K Takip Edilen1.7K Takipçiler
Vignesh Packiam, MD retweetledi
BackTable Urology
BackTable Urology@_backtableUro·
🎙️ Creator Weekend Nashville is in the books! We recorded 4 new episodes focused on advancing NMIBC care, covering a variety of topics from intravesical therapy to risk stratification and multidisplinary collaboration. Excited to share these soon! #BTCreatorWeekend #UroOnc #BladderCancer
BackTable Urology tweet mediaBackTable Urology tweet mediaBackTable Urology tweet mediaBackTable Urology tweet media
English
0
4
9
863
Vignesh Packiam, MD retweetledi
Roger Li
Roger Li@UrogerliMD·
4 drugs are approved to treat BCG unresponsive CIS, a small disease space with strict inclusion criteria Using Optum Market Clarity, we found: -Maintenance BCG is rarely given in real-world -BCG-exposed >> BCG-unresponsive NMIBC -BCG-exposed accounted for majority of rec/prog
English
1
4
29
3.9K
Vignesh Packiam, MD retweetledi
Rutgers Cancer Institute
Rutgers Cancer Institute@RutgersCancer·
Congratulations to Dr. Saum Ghodoussipour @saumyg, Director of the Bladder and Urothelial Cancer Program at @RutgersCancer @RWJBarnabas, on being the first recipient of the flagship LG-UTUC Luminaries recognition! This honor is given to leaders who demonstrate expertise, and a commitment to advancing low‑grade upper tract urothelial cancer care. Congratulations Dr. Ghodoussipour! 👏 finance.yahoo.com/sectors/health…
Rutgers Cancer Institute tweet media
English
5
9
53
3K
Vignesh Packiam, MD retweetledi
UroToday.com
UroToday.com@urotoday·
DRIFT: A floating device for intravesical gemcitabine-docetaxel delivery. James Byrne, MD, PhD @uiowa joins @UroDocAsh @UTMDAnderson to discuss the DRIFT - Drug-Releasing Intravesical Floating Technology for sequential gemcitabine-docetaxel delivery. #WatchNow > bit.ly/3PDEYdd
English
0
5
13
2K
Vignesh Packiam, MD retweetledi
Ashish M. Kamat, MD, MBBS
Ashish M. Kamat, MD, MBBS@UroDocAsh·
Pleased to share that the 2026 @NCCN Bladder Cancer Guidelines now incorporate the @IBCG_BladderCa risk stratification framework for intermediate-risk NMIBC. A milestone reflecting more than a decade of collaborative work by colleagues worldwide einpresswire.com/article/901009… @UrogerliMD @drtanws @shilpaonc @pjhensley11 @mouwlab @AndreaNecchi @LAUrology_NL @AmirHorowitz @karima_oualla @PGrivasMDPhD @paolo_gontero @pcvblack @MaxKates @SpiessPhilippe @RobertoContieri @KKBree @LauraBukavinaMD @MRoupret @joanfundi @UroToday @BladderCancerUS @WorldBladderCan
English
5
41
107
17.5K
Vignesh Packiam, MD retweetledi
Medical.watch
Medical.watch@MedicalwatchHQ·
💡 BCG-unresponsive NMIBC: efficacy is not the only question — value matters too. New study in European Urology analyzes the cost-effectiveness of treatments for BCG-unresponsive carcinoma in situ of the bladder. Key issue in modern #BladderCancer care: 🔹 Multiple new therapies emerging 🔹 Significant differences in cost and accessibility 🔹 Need to balance oncologic benefit, quality of life, and health-system sustainability 📌 As the therapeutic landscape expands, value-based decision making will be critical for patients worldwide. 🔗 lnkd.in/e7JyzqcF @AmandaMyersMD @RuchikaTalwarMD @pjhensley11 @SWilliams_MD @AmyLuckenbaugh @SewantiLimaye @WesKassouf @UrogerliMD @VigneshPackiam @BogdanaSchmidt @KKBree @AndreaNecchi @SimaPorten #NMIBC #UroOncology #HealthEconomics #EAU26 #OncoTwitter
European Urology@EUplatinum

📢 New publication in European Urology We are pleased to highlight a new study published in European Urology, titled "Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin–unresponsive Carcinoma in Situ of the Bladder". 👏 Congratulations to Myers A., @RuchikaTalwarMD , MMHC, and @UroDocAsh on this excellent contribution, together with all co-authors. 🔗 Read the full article here: 👉 lnkd.in/e7JyzqcF #EuropeanUrology #Urology #UroOncology #Research #MedicalResearch #AcademicUrology

English
1
4
8
992
Vignesh Packiam, MD retweetledi
Rutgers Cancer Institute
Rutgers Cancer Institute@RutgersCancer·
🌟 Program Spotlight! The Comprehensive Bladder Cancer Program at @RutgersCancer and @RWJBarnabas offers cutting-edge diagnostics and therapies, including blue-light cystoscopy, access to BCG, and all FDA-approved treatments for non–muscle-invasive bladder cancer. Leaders in the field, @RutgersCancer @RWJBarnabas experts Dr. Saum Ghodoussipour @saumyg and Dr. Vignesh Packiam @VigneshPackiam serve on national leadership committees for multiple trials and lead the most comprehensive bladder cancer clinical trial portfolio in the state of New Jersey.
Rutgers Cancer Institute tweet media
English
0
3
9
456
Vignesh Packiam, MD retweetledi
European Urology
European Urology@EUplatinum·
📢 New publication in European Urology We are pleased to highlight a new study published in European Urology, titled "Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin–unresponsive Carcinoma in Situ of the Bladder". 👏 Congratulations to Myers A., @RuchikaTalwarMD , MMHC, and @UroDocAsh on this excellent contribution, together with all co-authors. 🔗 Read the full article here: 👉 lnkd.in/e7JyzqcF #EuropeanUrology #Urology #UroOncology #Research #MedicalResearch #AcademicUrology
European Urology tweet media
English
2
12
46
7.3K
Vignesh Packiam, MD retweetledi
Rutgers Cancer Institute
Rutgers Cancer Institute@RutgersCancer·
#MicroscopeMonday ICYMI: @RutgersCancer @RWJBarnabas Dr. Saum Ghodoussipour, Dr. Vignesh Packiam, Dr. Tom Jang along with Dr. Hari S. Iyer and @RWJMS student Connor O'Leary have received a 2026 American Urological Association (AUA) Data Research Program Grant! @AmerUrological Their project uses U.S. real-world data to strengthen risk stratification models and advance intravesical therapies for non–muscle-invasive bladder cancer — work that continues to push the boundaries of precision care in urologic oncology. @saumyg @VigneshPackiam @TomJangUroOnc @hiyer_epi @Connor_J_OLeary
Rutgers Cancer Institute tweet media
English
0
3
5
346
Vignesh Packiam, MD retweetledi
David H Aggen, MD PhD
David H Aggen, MD PhD@Dr_Aggen·
#ASCOGU26 🧵3/5: NIAGARA utDNA data — first-ever utDNA with clinical correlation in a phase 3 periop trial. - Combined utDNA+ctDNA post-neoadjuvant/pre-cystectomy identified the highest 24-mo EFS group. - utDNA tracks residual non-invasive disease; ctDNA tracks invasive disease.
David H Aggen, MD PhD tweet mediaDavid H Aggen, MD PhD tweet mediaDavid H Aggen, MD PhD tweet mediaDavid H Aggen, MD PhD tweet media
English
2
13
29
1.9K
Vignesh Packiam, MD retweetledi
Matvey Tsivian
Matvey Tsivian@MatveyTsivian·
Excellent bladder cancer session with good friends at the Emory Advances in Urology led by Dr Joshi!
Matvey Tsivian tweet media
English
0
4
14
930
Vignesh Packiam, MD retweetledi
UroToday.com
UroToday.com@urotoday·
An #ArtificialIntelligence predictive biomarker for response to BCG vs gemcitabine-docetaxel for high-grade #NMIBC. @VigneshPackiam @RutgersCancer joins @UroDocAsh @MDAndersonNews to discuss an artificial intelligence test that analyzes digitized H&E slides from the index TURBT, examining over 600 microscopic features, including immune signatures, stromal features, and nuclear characteristics to predict patient response to treatment. #WatchNow > bit.ly/49vnhUx
English
1
6
8
1.1K
Vignesh Packiam, MD retweetledi
Laura Bukavina
Laura Bukavina@LauraBukavinaMD·
Huge congrats to our research team @CanDAydogdu @SeanTMcSweeney and collaborator @VigneshPackiam on this comprehensive review of the surgical management of bladder cancer relapse @CleClinicUro . Free access below 👇
Annals of Surgical Oncology@AnnSurgOncol

Featured: ASO Practice Guidelines Series: Surgical Management of #BladderCancer Relapse @CanDAydogdu @LauraBukavinaMD rdcu.be/e3uW6 @SyedAAhmad5 @SocSurgOnc

English
0
6
34
4.3K

Keşfet

@RutgersCancer @RWJBarnabas @saumyg @RWJUH @NYSAUA @IBCG_BladderCA @AmerUrological @spsutkaMD